Table: Mochida Pharm -2024/25 group results

Mochida Pharmaceutical

12/05/2025 06:00

May 12 (Reuters)- 
          Mochida Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2025    Mar 31, 2024   Mar 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          105.16          102.89         110.50                 
               (+2.2 pct)      (-0.4 pct)     (+5.1 pct)               
  Operating        8.13            5.80           7.00                 
               (+40.1 pct)     (-31.8 pct)    (-13.9 pct)              
  Recurring        8.07            6.04           7.50                 
               (+33.6 pct)     (-33.5 pct)    (-7.0 pct)               
  Net
  Net              5.69            4.55           5.40                 
               (+25.0 pct)     (-31.6 pct)    (-5.0 pct)               
  EPS          160.36 yen      126.80 yen     152.33 yen               
  Ann Div       80.00 yen       80.00 yen      80.00 yen               
  -Q2 Div       40.00 yen       40.00 yen      40.00 yen               
  -Q4 Div       40.00 yen       40.00 yen      40.00 yen               
  
  NOTE - Mochida Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4534.T